Core Laboratories (CLB) Operating Expenses (2022 - 2026)

Core Laboratories has reported Operating Expenses for 5 years, with the latest figure at $18.3 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 6.0% year-over-year to $18.3 million; the trailing twelve-month figure through Mar 2026 stood at $60.8 million (up 8.58% YoY), and the FY2025 full-year result was $59.7 million, up 10.15% from the prior year.
• Operating Expenses for Q1 2026 stood at $18.3 million, up from $14.2 million in the prior quarter.
• The five-year high for Operating Expenses was $18.3 million in Q1 2026, with the low at $3.7 million in Q4 2023.
• Historically, Operating Expenses has averaged $10.0 million across 5 years, with a median of $12.4 million in 2024.
• Annual changes were most pronounced in 2023 — Operating Expenses retreated 9.12% — and 2024, when it jumped 293.6%.
• Core Laboratories' Operating Expenses stood at $3.9 million in 2022, then slipped by 4.05% to $3.7 million in 2023, then surged by 236.89% to $12.6 million in 2024, then increased by 12.82% to $14.2 million in 2025, then grew by 28.35% to $18.3 million in 2026.
• The last three Operating Expenses figures came in at $18.3 million (Q1 2026), $14.2 million (Q4 2025), and $14.2 million (Q3 2025), per Business Quant data.